Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
Peter MacCallum Cancer Centre
Scientific Title
A Multi-centre Phase II Study to Determine the Response Kinetics, Safety and Efficacy of Pembrolizumab as Frontline Treatment of Patients With Hodgkin Lymphoma Considered Unsuitable for ABVD